Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells - Fusi, F; Ferrara, A; Zalatnai, A; Molnar, J; Sgaragli, G; Saponara, S (Cancer Chemother Pharmacol, 2008)